Technology transformation isn’t just about automation—it’s about aligning financial strategy, patient experience, and mission-driven outcomes.
In the latest episode of The Winning Edge, Moffitt Cancer Center’s VP of revenue cycle Lynn Ansley dove into the key considerations when investing in technology for revenue cycle.
Moffitt evaluates every revenue cycle technology investment by its impact on cost-to-collect, tying operational efficiency directly to the organization’s ability to fund cancer research. By integrating financial, IT, and clinical teams early in planning, Moffitt avoids the common pitfall of fragmented tech stacks and builds scalable, patient-centered solutions.
Check out what Ansley had to say for healthcare leaders looking to bring on new technology in the revenue cycle.
Also check out the accompanying article here.
Marie DeFreitas is the CFO editor for HealthLeaders.